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Case Report

Bone in the breast: A case report of a metaplastic
breast cancer with osseous differentiation ✩
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Metaplastic breast carcinoma is an uncommon malignant tumor with various pathologic
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subtypes. Diagnosis is often challenging due to the wide spectrum of clinical and imag-
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ing presentations. Here, we present the case of a very rare subtype of metaplastic breast
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carcinoma—a mixed-type metaplastic breast cancer with osseous differentiation in a 55-
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year-old female patient. The clinical presentation, imaging-pathology diagnosis, and treatment options are reviewed. Knowing this rarely reported but aggressive breast cancer is very
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important for clinicians to establish a timely diagnosis for effective management.
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
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Introduction
Metaplastic breast carcinoma (MBC) is an uncommon invasive
tumor that makes up less than 1% of primary breast cancers
[1] that was not recognized as a distinct histologic entity
until 2000 [2]. MBC is a heterogeneous disease with many
pathologic subtypes characterized by a mixture of adenocarcinoma with components of squamous, spindle, osseous, and
chondroid differentiation [1]. It is challenging to diagnose

MBC because it has a broad spectrum of imaging and clinical
presentations. Radiologists and clinicians have limited experience in the diagnosis and management of MBC because it is
an uncommon disease and is poorly documented in literature.
Here, we report a case of a very rare subtype of MBC—a
mixed-type metaplastic breast cancer with osseous differentiation. The multimodality imaging features along with the
pathology correlation is presented and the multidisciplinary
treatment approach is also reviewed. This case report will augment our understanding of this rare subtype of MBC.

✩
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Fig. 1 – Mammogram craniocaudal (A) and mediolateral
oblique (B) views of the left breast demonstrate a
circumscribed irregular mass with coarse calcifications in
the posterior 12 o’clock axis. The triangular marker
indicates the palpable concern.

Case report
A 55-year-old female presented with a palpable abnormality in
the left breast. The patient had no personal or family history
of breast cancer. Bilateral mammograms were performed and
showed a 35-mm circumscribed irregular mass with coarse
calcifications in the left breast at 12 o’clock located 8 cm from
the nipple (Fig. 1). This correlated with the palpable concern.
A focused ultrasound was performed in the area of concern for further evaluations and indicated an irregular mass
with internal vascularity measuring 39 × 21 × 29 mm (Fig. 2).
The mass was predominantly hypoechoic with an echogenic
component corresponding to the coarse calcifications on
the mammogram. The noncalcified component demonstrated
posterior acoustic enhancement. The mass appeared to be in
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close proximity to the underlying pectoralis muscle. A focused
ultrasound was also performed in the left axilla and showed
a few normal lymph nodes (images not shown).
A percutaneous core needle biopsy of the mass was performed with a 12-gauge spring-loaded needle device (Bard
Marquee, Q123). Histopathology of the core biopsy indicated
a mixed adenocarcinoma with a spindle area and osteoid matrix (Fig. 3). Immunohistochemistry was negative for estrogen
and progesterone receptors as well as HER2 and melanoma
markers. Immunohistochemistry also indicated no specific
mesenchymal, neural, muscle, or endothelial cell differentiation.
A 1.5-Tesla magnet breast MRI was performed to delineate
the extent of the cancer, especially the pectoral muscle
involvement. The MRI indicated a mass with heterogeneous
enhancement measuring 40 × 41 × 34 mm in the posterior
left breast located at the 12:00 position (Fig. 4). The kinetics
showed at worst a rapid initial enhancement followed by
washout. This enhancing mass contained an artifact from
the biopsy clip consistent with the biopsy proven malignancy.
The mass was compressing the pectoralis major without definite muscular enhancement. However, the fat plane between
the mass and the pectoralis major was obliterated. CT images
of the chest, abdomen and pelvis showed the biopsied left
breast mass and calcifications of bone density without distant
metastasis (Fig. 5).
The patient underwent a lumpectomy of the left breast, including a resection of the left breast cancer as well as a portion of the underlying pectoralis major given its proximity to
the cancer. The patient also underwent 4 cycles of Carboplatin
and Taxol chemotherapy treatment in addition to radiation
therapy.
The patient was recommended to have a routine annual clinical follow-up with bilateral mammograms. At the
1-year follow-up, the patient denied any major complaints.
No masses were felt on physical examination or seen on the
mammograms.

Discussion
MBC is an uncommon, heterogeneous group of cancer
with various pathologic subtypes. Mixed MBC with osseous

Fig. 2 – Ultrasound imaging demonstrates a circumscribed irregular mass with rim vascularity at the area of palpable
concern. The internal echotexture is heterogeneous. The echogenic area (arrow) corresponds to the coarse calcification on
mammogram. The noncalcified component shows posterior acoustic enhancement (circle).
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Fig. 3 – Histopathologic findings with (J) lower and (K) higher power magnification showing the interface between the
spindle area and osteoid matrix.

Fig. 4 – MRI images [(F) Maximum Intensity Projection Image, (G) T1 without contrast, (H) T1 with contrast enhancing, and (I)
T1 with contrast and color mapping] show a circumscribed mass with a kinetics pattern of at worst rapid initial
enhancement followed by washout at the left breast. There is a signal void from the biopsy clip in the center of this
enhancing mass. This mass is close to the pectoralis muscle.

differentiation is a very rare subtype with limited literature
reports [3]. The median age at the time of presentation is
48-59 years and it usually presents as a rapidly growing
palpable mass generally greater than 2.0 cm in presentation
[2]. Despite its large size, axillary involvement is much less
common (6%-26% of cases) when compared with invasive
ductal carcinoma [2]. MBC demonstrates a tendency to spread
to lung and bone tissue by hematogenous means [4].
Histologically, MBC is a poorly differentiated heterogeneous tumor containing ductal carcinoma cells mixed with
areas of spindle, squamous, chondroid, or osseous elements
[5]. The wide range of microscopic appearances of MBC has resulted in a variety of classifications and designations with the
World Health Organization dividing MBC into epithelial and
mixed types [6]. The mixed type category is further divided
into carcinosarcomas, carcinomas with chondroid differenti-

ation and carcinomas with osseous differentiation. The broad
spectrum of MBC pathology often leads to various clinical and
imaging presentations which makes its diagnosis and treatment challenging.
MBC often demonstrates triple negative biomarkers (estrogen receptor, progesterone receptor and Her2-neu) and as
such is difficult to treat. When compared with other breast
cancers, there are fewer therapeutic options and the outcomes are generally poorer with a higher recurrence rate.
Previous studies indicate that MBC has a poor response to
systemic chemotherapy and that neoadjuvant chemotherapy
has little effect in preventing its progression [7]. Thus, aggressive surgical interventions with wide local excision of
the lesion are often required due to the high recurrence rate.
However, there is no consensus of the specific surgical margins.
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Fig. 5 – CT axial (D) and sagittal (E) images of the chest show the left breast mass with calcifications of dense bone density.

The mixed MBC with osseous differentiation we reported
is a very rare subtype of MBC. It has a few unique imaging features that make it more difficult to diagnose as it often demonstrates benign features that hide its malignant nature. MBC
commonly presents as a round and circumscribed mass with
posterior acoustic enhancement, rather than the irregular
shape and posterior acoustic shadowing that is demonstrated
in other malignant breast cancers [3,8]. The dense calcifications that were observed in the case report are the “bone”—
osseous components of the lesion which are not commonly
seen in the breast cancer [8]. The circumscribed mass and
coarse calcifications can mimic benign fibroadenoma with
hyalinized calcifications or trauma with dystrophic calcifications. A history of rapid growth and high clinical suspicion
will help differentiate MBC from other benign breast conditions. Multimodality imaging, including a breast MRI, defines
the extent of the disease and CT imaging helps rule out metastasis. In this case, a multidisciplinary clinical team decided on
a wide surgical excision with chemoradiation therapy and the
patient responded well to this treatment approach.

Conclusion
Mixed MBC with osseous differentiation is a very rare type
of breast cancer that often presents as a circumscribed mass
with coarse calcifications on imaging. As a triple negative
breast cancer, it is limited in the available treatment options.
Timely diagnosis and wide surgical resection are keys for successful management of this rapidly growing cancer.

Consent statement
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